Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3745
-0.0120 (-3.10%)
At close: Dec 5, 2025, 4:00 PM EST
0.3700
-0.0045 (-1.20%)
After-hours: Dec 5, 2025, 7:57 PM EST
Co-Diagnostics Employees
Co-Diagnostics had 132 employees as of December 31, 2024. The number of employees decreased by 23 or -14.84% compared to the previous year.
Employees
132
Change (1Y)
-23
Growth (1Y)
-14.84%
Revenue / Employee
$3,848
Profits / Employee
-$243,799
Market Cap
22.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CODX News
- 16 days ago - Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - PRNewsWire
- 18 days ago - Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - PRNewsWire
- 22 days ago - Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Co-Diagnostics Reports Third Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Co-Diagnostics, Inc. (CODX) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments Transcript - Seeking Alpha
- 4 weeks ago - Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd - PRNewsWire
- 4 weeks ago - Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast - PRNewsWire